Nick Sosiak is the CFO of Cannara Biotech, a vertically integrated producer for the Québec and Canadian markets.
- The current state of the second wave of Canadian LPs
- Shifting focus from cultivation to CPG
- Product formulation trends in Canada
- Canadian cannabis marketing restrictions
- Genetics to keep SKUs fresh and maintain sales volume